This epidemiological evidence, combined with the direct presence of GLP-1 receptors in the brain, has prompted researchers to explore whether these medications might offer cognitive benefits independent of their metabolic effects
Monitoring and Follow-Up Establish a structured monitoring schedule: Monthly visits during dose titration and the first 6 months Quarterly visits once stable, assessing weight, tolerability, and metabolic parameters Annual comprehensive evaluation including lipid panel, HbA1c (if diabetic), liver function tests, and cardiovascular risk assessment Regular monitoring allows early identification of plateaus, adverse effects, or emerging medical issues that may require intervention
It is important to note that while the formulation of Replenza GLP-1 Support aims at complementing the natural functions of GLP-1, users may wish to consult healthcare professionals to ensure it aligns with their personal health goals and conditions
Kristensen SL, Rrth R, Jhund PS et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
An improved 9-herbal formula, FAHF-2, whereby zhi fu zi and xi xin were eliminated, was tested for efficacy compared to FAHF-1 [33]
doi: 10.1126/science.271.5257.1854
